Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001638599-17-000704

Options or other derivatives

  • CFO and Treasurer acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Siewers David · CFO and Treasurer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-07-07 Grant or award : show line 1 in the form Stock Option (Right to Buy) +20,000 $19.33 2027-07-06 20,000 20,000 D
Loading xslF345X03/doc4_4848.xml…